Managed Care Entity Web Portal training recording now available The recorded SPBM Web Portal training is now available for Managed Care Entity Portal Administrators and staff
While federal law has long carved out exceptions for pharmacists to mix custom medications for individual patients, the sheer scale of current operations has blurred the line between traditional pharmacy practice and unapproved manufacturing. For intellectual property (IP) attorneys, regulatory affairs directors, and biopharma executives, the urgent question is no longer theoretical: At what point does the volume, scale, and marketing of a compounded drug cease to be a regulatory exemption and become actionable patent infringement
Most patients are able to feel the effects of their semaglutide treatments immediately following their first dose, as their appetite is suppressed and they feel fuller from smaller portions of food for longer periods of time than typical
TV has served on scientific advisory panels for, been part of speakers bureaus for, served as a consultant to, and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gilead, Mundipharma, MSD/ Merck, Novo Nordisk, and Sun Pharmaceutical Industries
Its really great to see
Medication adherence to injectable glucagon-like peptide-1 (GLP-1) receptor agonists dosed once weekly vs once daily in patients with type 2 diabetes: a meta-analysis
